Home › Funds › Arete Wealth Advisors, LLC › JNJ

Arete Wealth Advisors, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Arete Wealth Advisors, LLC reported holding 73,502 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$19.5M, representing 1.23% of its reported portfolio and ranking #15 among its reported holdings. Arete Wealth Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)73.50K sh
Reported value held$19.48M
Portfolio Weight1.23%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Arete Wealth Advisors, LLC's JNJ position evolved

Arete Wealth Advisors, LLC first disclosed a stake in JNJ in Q3 2023 at 23,358 shares (US$3.6M). The position peaked in Q1 2026 at 80,292 shares, worth US$19.6M. Across 13 filings, Arete Wealth Advisors, LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 73,502 shares valued at US$19.5M — an increase of 2,615 shares quarter over quarter.. Notable position changes include a 308% increase in Q2 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 23.36K $3.64M New
Q4 2023 23.98K $3.76M Add
Q1 2024 20.59K $3.26M Reduce
Q2 2024 19.06K $2.78M Reduce
Q3 2024 15.66K $2.53M Reduce
Q4 2024 16.95K $2.44M Add
Q1 2025 16.97K $2.81M Hold
Q2 2025 69.29K $10.58M Add
Q3 2025 69.69K $12.92M Add
Q4 2025 68.50K $14.18M Reduce
Q1 2026 80.29K $19.63M Add
Q2 2026 70.89K $18.00M Reduce
Q3 2026 73.50K $19.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Arete Wealth Advisors, LLC held JNJ?

Arete Wealth Advisors, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Arete Wealth Advisors, LLC's current position in JNJ?

As of Q3 2026, Arete Wealth Advisors, LLC holds 73.50K shares of JNJ (JOHNSON & JOHNSON), valued at $19.48M, representing 1.23% of its reported portfolio and ranking #15.

Has Arete Wealth Advisors, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Arete Wealth Advisors, LLC increased its position in JNJ. The position peaked in Q1 2026 at 80.29K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.